Te Ahumairangi Investment Management Ltd
Position in MRK — Merck & Co., Inc.
CIK 1832237
WELLINGTON, Q2
Position in MRK
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$6,490,663
-$1,156,052 QoQ
Shares Held
50,511
-20.5% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.05%
of 13F equity value
Holder Rank
#926
of 3,769 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Te Ahumairangi Investment Management Ltd holds $45,755,777 across 8 Drug Manufacturers - General names. MRK ranks #3 (14.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
31,084 | $7,894,403 | |
| 2 | AZN |
Astrazeneca PLC
|
34,479 | $6,537,907 | |
| 3 | MRK |
Merck & Co., Inc.
This page
|
50,511 | $6,490,663 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
48,936 | $6,182,574 | |
| 5 | PFE |
Pfizer Inc
|
237,946 | $5,729,739 | |
| 6 | ABBV |
AbbVie Inc.
|
21,083 | $5,305,326 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
79,705 | $4,592,602 | |
| 8 | LLY |
ELI LILLY & Co
|
2,520 | $3,022,563 |
All Filings in MRK
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,490,663 | 50,511 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $7,646,715 | 63,569 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $8,655,108 | 82,226 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $8,897,167 | 106,007 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $8,685,197 | 109,717 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $8,834,717 | 98,426 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $10,544,979 | 106,001 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $12,611,632 | 111,057 | Shares | Sole | 2024-11-21 | |
| 2024-06-30 | $11,919,092 | 96,277 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $13,813,317 | 104,686 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $12,510,699 | 114,756 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $13,800,138 | 134,047 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $15,677,693 | 135,867 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $13,304,814 | 125,057 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $13,556,092 | 122,182 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $10,957,650 | 127,237 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $12,702,898 | 139,332 | Shares | Sole | 2022-08-16 | |
| 2022-03-31 | $11,574,957 | 141,072 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $10,212,433 | 133,252 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $9,978,513 | 132,852 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $10,067,482 | 129,452 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $11,022,488 | 142,982 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $9,421,883 | 115,182 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $7,663,090 | 92,382 | Shares | Sole | 2020-11-17 | |
| No filing history on record for this holder in this stock. | ||||||